Hysteroscopic surgery does not adversely affect the long-term prognosis of women with endometrial adenocarcinoma

Journal of Minimally Invasive Gynecology

Volumn 14, Issue 2, 2007, Pages 205-210

  Vilos, George A ^a   Edris, Fawaz ^a   Al Mubarak, Awatif ^a   Ettler, Helen C ^a   Hollett Caines, Jackie ^a   Abu Rafea, Basim ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

Endometrial adenocarcinoma; Hysteroscopy; Resectoscopic surgery; Uterine cancer

Indexed keywords

GESTAGEN;

ACUTE KIDNEY FAILURE; ADULT; AGED; ARTICLE; CANCER SURGERY; CANCER SURVIVAL; CAUSE OF DEATH; CLINICAL ARTICLE; CONTROLLED STUDY; ELECTROCOAGULATION; ENDOMETRIUM ABLATION; ENDOMETRIUM CARCINOMA; ENDOMETRIUM HYPERPLASIA; FEMALE; FEMALE FERTILITY; FOLLOW UP; GALLBLADDER CARCINOMA; GYNECOLOGIC SURGERY; HUMAN; HYSTERECTOMY; HYSTEROSCOPY; INTERVIEW; OUTCOME ASSESSMENT; PRACTICE GUIDELINE; PROGNOSIS; TELEPHONE; TREATMENT PLANNING;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; COHORT STUDIES; DISEASE-FREE SURVIVAL; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; HYSTEROSCOPY; MIDDLE AGED; PROGNOSIS; UTERINE HEMORRHAGE;

EID: 33947149064     PISSN: 15534650     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmig.2006.10.010     Document Type: Article

References (31)

1. Hallberg L., Hogdahl A.M., Nilsson L., and Rybo G. Menstrual blood loss: a population study-variation at different ages and attempts to define normality. Acta Obstet Gynecol Scand 45 (1966) 320-351
2. Shapley M., Jordan K., and Croft P.R. An epidemiological survey of symptoms of menstrual loss in the community. Br J Gen Pract 54 (2004) 359-363
3. Rose P.G. Endometrial carcinoma. N Engl J Med 335 (1996) 640-649
4. Farquhar C.M., Lethaby A., Sowter M., Verry J., and Baranyai J. An evaluation of risk factors for endometrial hyperplasia in premenopausal women with abnormal menstrual bleeding. Am J Obstet Gynecol 181 (1999) 525-529
5. Orr J.J., Chamberlain D., Kilgone L., and Naumann W. Management of endometrial cancer. American College of Obstetricians and Gynecologists (ACOG) Practice Bulletins. Number 65. August 2005. Obstet Gynecol 106 (2005) 413-425
6. Spencer C.P., and Whitehead M.I. Endometrial assessment re-visited (Review). Br J Obstet Gynaecol 106 (1999) 623-632
7. Vilos G.A. Hysteroscopic and nonhysteroscopic endometrial ablation. Obstet Gynecol Clin North Am 31 (2004) 687-704 xi
8. Vilos G.A., Lefebvre G., and Graves G.R. Guidelines for the management of abnormal uterine bleeding. Society of Obstetrics and Gynaecology of Canada (SOGC) Clinical Practice Guidelines. J Obstet Gynaecol Can 23 (2001) 704-709
9. Vilos G.A., Harding P.G., Silcox J.A., Sugimoto A.K., Carey M., and Ettler H.C. Endometrial adenocarcinoma encountered at the time of hysteroscopic endometrial ablation. J Am Assoc Gynecol Laparosc 9 (2002) 40-48
10. Vilos A.G., Ettler H.C., Edris F., Hollett-Caines J., and Abu-Rafea B. Endometrioid adenocarcinoma treated by hysteroscopic endomyometrial resection: a case report. J Minim Invasive Gynecol 14 (2007) 119-122
11. Brand A., Dubuc-Lissoir J., Ehlen T.G., and Plante M. Diagnosis of endometrial cancer in women with abnormal vaginal bleeding: SOGC clinical practice guidelines. J Soc Obstet Gynaecol Can 22 (2000) 102-104
12. Romano S., Shimoni Y., Muralee D., and Shalev E. Retrograde seeding of endometrial carcinoma during hysteroscopy. Gynecol Oncol 44 (1992) 116-118
13. Schmitz M.J., and Nahhas W.A. Hysteroscopy may transport malignant cells into the peritoneal cavity: case report. Eur J Gynaecol Oncol 15 (1994) 121-124
14. Egarter C., Krestan C., and Kurz C. Abdominal dissemination of malignant cells with hysteroscopy. Gynecol Oncol 63 (1996) 143-144
15. Zerbe M.J., Zhang J., Bristow R.E., Grumbine F.C., Abularach S., and Montz F.J. Retrograde seeding of malignant cells during hysteroscopy in presumed early endometrial cancer. Gynecol Oncol 79 (2000) 55-58
16. Obermair A., Geramou M., Gucer F., et al. Does hysteroscopy facilitate tumor cell dissemination?. Incidence of peritoneal cytology from patients with early stage endometrial carcinoma following dilatation and curettage (D & C) versus hysteroscopy and D & C. Cancer 88 (2000) 139-143
17. Dessole S., Rubattu G., Farina M., et al. Risks and usefulness of sonohysterography in patients with endometrial carcinoma. Am J Obstet Gynecol 194 (2006) 362-368
18. Wilson A., and Duncan A. Peritoneal seeding after hysteroscopic diagnosis of cervical adenocarcinoma. Gynaecol Endosc 8 (1999) 179-181
19. Benifla J.L., Filippini F., Darai E., et al. Operative hysteroscopy procedure on an unsuspected mixed mullerian tumor of the uterus. Gynaecol Endosc 6 (1997) 147-149
20. Nagele F., Wieser F., Deery A., Hart R., and Magos A. Endometrial cell dissemination at diagnostic hysteroscopy: a prospective randomized cross-over comparison of normal saline and carbon dioxide uterine distension. Hum Reprod 14 (1999) 2739-2742
21. Gu M., Shi W., Huang J., Barakat R.R., Thaler H.T., and Saigo P.E. Association between initial diagnostic procedure and hysteroscopy and abnormal peritoneal washings in patients with endometrial carcinoma. Cancer 90 (2000) 143-147
22. Grimshaw R.N., Tupper W.C., Fraser R.C., Tompkins M.G., and Jeffrey J.F. Prognostic value of peritoneal cytology in endometrial carcinoma. Gynecol Oncol 36 (1990) 97-100
23. Morrow C.P., Bundy B.N., Kurman R.J., et al. Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study. Gynecol Oncol 40 (1991) 55-65
24. Kadar N., Homesley H.D., and Malfetano J.H. Positive peritoneal cytology is an adverse factor in endometrial carcinoma only if there is other evidence of extrauterine disease. Gynecol Oncol 46 (1992) 145-149
25. Milosevic M.F., Dembo A.J., and Thomas G.M. The clinical significance of malignant peritoneal cytology in stage I endometrial carcinoma. Int J Gynecol Cancer 2 (1992) 225-235
26. Takeshima N., Nishida H., Tabata T., Hirai Y., and Hasumi K. Positive peritoneal cytology in endometrial cancer: enhancement of other prognostic indicators. Gynecol Oncol 82 (2001) 470-473
27. Hirai Y., Takeshima N., Kato T., and Hasumi K. Malignant potential of positive peritoneal cytology in endometrial cancer. Obstet Gynecol 97 (2001) 725-728
28. Gucer F., Tamussine K., Moser F., et al. Two-year followup of patients with endometrial carcinoma after preoperative fluid hysteroscopy. Int J Gynecol Cancer 8 (1998) 476-480
29. Swartz M.A., Kristensen C.A., Melder R.J., et al. Cells shed from tumours show reduced clonogenicity, resistance to apoptosis, and in vivo tumorigenicity. Br J Cancer 81 (1999) 756-759
30. Chambers A.F., Naumov G.N., Vantyghen S.A., et al. Breast cancer metastasis: clinical implications of experimental studies on metastatic inefficiency. Breast Cancer Res 2 (2000) 400-407
31. Wyckoff J.B., Jones J.G., Condeelis J.S., and Segall J.E. A critical step in metastasis: in vivo analysis of intravasation at the primary tumor. Cancer Res 60 (2000) 2504-2511